Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Jaguar Health (JAGX) Preferred Shares Issued (2018 - 2019)

Jaguar Health (JAGX) has disclosed Preferred Shares Issued for 2 consecutive years, with -$2.1 million as the latest value for Q4 2019.

Quarterly Preferred Shares Issued fell 1154.16% to -$2.1 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.4 million for FY2025, N/A changed from the prior year.
Preferred Shares Issued for Q4 2019 was -$2.1 million at Jaguar Health, down from $199000.0 in the prior quarter.
The five-year high for Preferred Shares Issued was $199000.0 in Q4 2018, with the low at -$2.1 million in Q4 2019.